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Abstract 
Background: As autotrophic prokaryotes, cyanobacteria are ideal chassis organisms for sustainable production 
of various useful compounds. The newly characterized cyanobacterium Synechococcus elongatus UTEX 2973 is a 
promising candidate for serving as a microbial cell factory because of its unusually rapid growth rate. Here, we seek 
to develop a genetic toolkit that enables extensive genomic engineering of Synechococcus 2973 by implementing a 
CRISPR/Cas9 editing system. We targeted the nblA gene because of its important role in biological response to nitro-
gen deprivation conditions.
Results: First, we determined that the Streptococcus pyogenes Cas9 enzyme is toxic in cyanobacteria, and conjuga-
tional transfer of stable, replicating constructs containing the cas9 gene resulted in lethality. However, after switching 
to a vector that permitted transient expression of the cas9 gene, we achieved markerless editing in 100 % of cyano-
bacterial exconjugants after the first patch. Moreover, we could readily cure the organisms of antibiotic resistance, 
resulting in a markerless deletion strain.
Conclusions: High expression levels of the Cas9 protein in Synechococcus 2973 appear to be toxic and result in cell 
death. However, introduction of a CRISPR/Cas9 genome editing system on a plasmid backbone that leads to transient 
cas9 expression allowed for efficient markerless genome editing in a wild type genetic background.
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Background
Photosynthetic microbes are of considerable interest for 
applications in carbon sequestration, photosynthetic 
production of fuels, and biosynthesis of other valuable 
chemicals such as pharmaceuticals [1, 2]. The advantage 
of using cyanobacteria as biofactories is that they grow 
on CO2 and sunlight alone; this reduces greenhouse gas 
emissions and decreases dependence on petroleum-
based products. Furthermore, cyanobacteria are the 
evolutionary ancestors of plastids and serve as model 
organisms for the study of the photosynthetic apparatus. 
Commonly studied cyanobacteria such as Synechococcus 
elongatus PCC 7942, Synechococcus sp. PCC 7002, and 
Synechocystis sp. PCC 6803 have been genetically engi-
neered to generate a variety of useful products including 
ethylene [3], hydrogen [4], free fatty acids [5], ethanol [6], 
and isoprene [7]. Additionally, genetic manipulation has 
been used to rewire central metabolism and redirect car-
bon sequestration into end products by deleting compet-
ing pathways [8, 9].
A newly identified cyanobacterial strain that has the 
potential to become a versatile chassis for metabolic engi-
neering and biological discovery is Synechococcus 2973. 
With a 1.9-h doubling time, Synechococcus 2973 has a 
growth rate akin to that of Saccharomyces cerevisiae [10]. 
The genome sequence of Synechococcus 2973 is 99.8  % 
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identical to that of the model organism Synechococcus 
7942, which has a slower doubling time of 4.9  h. How-
ever, the development of Synechococcus 2973 as a model 
organism has been hindered by the lack of an efficient 
genetic modification system. Synechococcus 7942 is natu-
rally competent, whereas Synechococcus 2973 does not 
have the capacity to take up naked DNA. Although Syn-
echococcus 2973 has proven to be capable of conjugative 
transfer of DNA, the rate at which subsequent genome 
modification occurs is less than that found in Synechococ-
cus 7942 and other model species of cyanobacteria.
The current genetic manipulation system for Synechoc-
occus species is well developed, however, it often requires 
a significant amount of time to generate the desired 
mutant strains. The strategy typically used for engineer-
ing a deletion mutant in Synechococcus relies on double 
homologous recombination between a suicide vector and 
host chromosome, and involves replacing the gene of 
interest with a selective marker [11]. Additional genetic 
alterations are made by integrating other antibiotic 
resistance markers. This restricts pathway engineering 
because there are a limited number of antibiotic cas-
settes available. Moreover, cyanobacteria maintain mul-
tiple copies of their chromosome and numerous rounds 
of segregation are often necessary to obtain a completely 
segregated mutant [12]. Although the genome copy num-
ber for Synechococcus 2973 is yet to be determined, Syne-
chococcus 7942 cells contain three to four genome copies. 
As a result, the process of segregation can take weeks 
of restreaking on selective media to obtain a segregated 
strain.
Alternatively, markerless deletion strategies have been 
developed that rely on a dominant streptomycin-sensitive 
rps12 mutation [13]. A major drawback of this system 
is that it requires working in a genetic background that 
contains the appropriate rps12 mutation. Additionally, 
this strategy is time-consuming because it relies on two 
subsequent rounds of transformation. Recently, CRISPR/
Cas9 systems have emerged as versatile editing platforms 
for engineering markerless mutations in a wide variety of 
organisms [14–16]. However, a CRISPR/Cas9 system for 
markerless genome editing in cyanobacteria has not yet 
been developed.
In nature, the CRISPR (clustered regularly interspaced 
short palindromic repeats)/Cas9 (CRISPR associated 
protein 9) system provides adaptive immunity in bacte-
ria against invading viruses or plasmids by cleaving and 
degrading the exogenous DNA [17]. Upon infection, 
invader sequences are incorporated as spacers between 
a series of palindromic repeats in a CRISPR array [18, 
19]. The CRISPR array transcripts are then processed 
into two RNA components: the crRNA and tracrRNA 
[20]. These are used to guide the Cas9 nuclease to the 
complementary target sequence, where Cas9 creates a 
double stranded break [18]. The CRISPR system can be 
engineered for genome editing by reprogramming the 
spacer sequences to be complementary to the genetic 
target [21]. The directed break is subsequently repaired 
by double homologous recombination, during which 
a homologous sequence serves as a repair template 
[22, 23]. By providing a repair template containing the 
desired change to the target sequence, specific genomic 
mutations or deletions may be made at the cut site. 
Although there are not yet any instances of application of 
a CRISPR/Cas9 genome editing system in cyanobacteria, 
studies have been performed that aim to characterize the 
native cyanobacterial CRISPR system [24, 25]. Little work 
has been performed to characterize the CRISPR/Cas sys-
tem in Synechococcus elongatus. However, computational 
analysis of various cyanobacterial genomes has predicted 
the presence of various combinations of IA, IB, IIA, 
IIB, IIC, IID, IIE, IIF, IIG, and III CRISPR/Cas subtypes 
[24, 26]. Furthermore, recent studies have been aimed 
at developing a CRISPRi system for gene repression in 
cyanobacteria [27].
In the current study, we repurposed a CRISPR/Cas9 
system, originally developed for genome editing in Strep-
tomyces lividans, for use in the fast-growing cyanobac-
terium Synechococcus 2973 [28]. Using derivatives of the 
pCRISPomyces plasmids, we introduced a markerless 
deletion into Synechococcus 2973 and determined that 
the mutated strain was completely segregated in the first 
patch. In addition to serving as metabolic chassis, cyano-
bacteria are ideal systems for better understanding pho-
tosynthetic processes [29]. Thus, as a proof of concept 
for the ability to generate a markerless deletion mutant 
with the CRISPR/Cas9 system, we chose to target the 
nblA gene, which has an important function in cellular 
response to nutrient deprivation conditions. Cyanobac-
teria have large antenna protein complexes that harvest 
light for photosynthesis [30]. One intriguing feature of 
these prokaryotes is their ability to modulate the size and 
structure of these antenna complexes based on nutri-
ent availability [31]. NblA is involved in the degradation 
of phycobilisomes, one of the primary antenna protein 
complexes associated with photosystem II [32]. By target-
ing nblA for deletion, we demonstrate that the CRISPR/
Cas9 system can be used to better characterize the func-
tion of biologically important genes.
This improved method of genome editing is expected 
to facilitate rapid and efficient genetic engineering of Syn-
echococcus strains. Moreover, the number of edits that 
can be made using CRISPR/Cas9 editing is not limited 
by choice of antibiotic cassettes and will enable extensive 
modification of host genomes for the production of use-
ful bioproducts.
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Results
Developing an RSF1010‑based CRISPR/Cas9 system
We initially attempted to assemble a complete CRISPR 
system using the medium copy number plasmid back-
bone pVZ321, an RSF1010 based backbone, which is 
stably maintained in cyanobacteria [33, 34]. We selected 
the nblA gene, an essential element for phycobilisome 
degradation in Synechococcus 2973, as a target for dele-
tion [32]. These mutants have a phenotype that can be 
detected visually. While the wild type Synechococcus 
2973 strain exhibits yellow bleaching that is characteristic 
of phycobilisome degradation when grown in media lack-
ing nitrate, the ∆nblA strain has an obvious non-bleach-
ing phenotype and remains green under these conditions. 
Furthermore, bleaching is only apparent when all copies 
of nblA have been deleted, allowing it to serve a visual 
marker for segregation.
The construct pVZ321 was engineered to contain S. 
pyogenes cas9 (derived from pCRISPomyces-2), a syn-
thetic guide RNA (sgRNA) designed to target nblA, and 
an editing template to introduce the nblA deletion. After 
multiple conjugation attempts with this construct, we 
were unable to recover exconjugants. However, the same 
backbone lacking the CRISPR/Cas9 system yielded ~250 
colonies in each of two conjugation attempts. To assay for 
cas9 toxicity, we proceeded by engineering the pVZ321 
backbone to contain only cas9. Once again we were 
unable to recover colonies from conjugation with the 
cas9 containing plasmid. In an effort to circumnavigate 
toxicity from cas9, we reduced expression to basal level 
by removing 500 base pairs of the upstream sequence, 
including the ribosome binding site and promoter. Con-
jugation of the resulting plasmid into Synechococcus 
2973 yielded less than five exconjugants in each of two 
attempts, while the vector without cas9 yielded ~250 
exconjugants.
Applying the pCRISPomyces‑2 CRISPR/Cas9 system
Experiencing little success with the pVZ321 backbone, 
we switched to a vector that would theoretically allow 
for transient expression of cas9: the pCRISPomyces-2 
construct from the Zhao lab. Replication of this vector is 
dependent on a Streptomyces ghanaensis pSG5 origin of 
replication, which is not functional at temperatures above 
34 °C [35]. In our study, all conjugation experiments were 
performed 38  °C (the optimal temperature for Synecho-
coccus 2973), which is above the permissive replication 
temperature in S. ghanaensis. This allows for initial tran-
sient expression of cas9 directly after its conjugation into 
Synechococcus 2973, but prevents prolonged expression 
of the toxic gene because the plasmid presumably does 
not replicate after it is transformed into the cyanobacte-
ria. We modified the pCRISPomyces-2 vector to target 
nblA in Synechococcus 2973 by inserting an sgRNA that 
targets nblA and an editing template designed to intro-
duce the nblA deletion (Fig. 1a).
We employed a deletion strategy that would not rely 
on the integration of a selective marker into the genome 
as a proof-of-concept for making a markerless genome 
modification. Triparental mating was used to intro-
duce the ∆nblA CRISPR construct into Synechococcus 
2973. Antibiotic selection was used to force temporary 
persistence of the plasmid at a basal level. A typical 
conjugation yielded 21 colonies and a subset of these 
exconjugants was assayed for bleaching in media lacking 
nitrate (Fig. 2). Additionally, PCR and Sanger sequencing 
were used to confirm that the non-bleaching phenotype 
was the result of nblA deletion and not a single recombi-
nation event in colonies that failed to bleach under nitro-
gen deprivation conditions.
Evaluating CRISPR/Cas9 mediated editing
To determine the proportion of editing that is depend-
























Fig. 1 Plasmids were generated using pCRISPomyces-2 backbone to 
engineer the ∆nblA line. a The nblA deletion plasmid including cas9 
and b the nblA editing plasmid excluding cas9 are depicted
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which the cas9 gene was deleted (Fig.  1b). Triparental 
mating was used to introduce the -cas9 construct into 
Synechococcus 2973 to compare differential exconjugant 
yields. We used PCR to assess whether exconjugants 
were edited and segregated (Table 1; Fig. 3).
The presence of antibiotic resistant exconjugants sug-
gested that the editing plasmid was being maintained, 
even under conditions that were supposedly non-per-
missive for replication. We confirmed this by performing 
PCR assays to test for the presence of cas9 in exconju-
gants (Fig. 4).
Assessing the potential to cure edited strains of CRISPR 
plasmid machinery
In order to determine whether exconjugants could be 
cured of cas9 and the apramycin-resistance marker, colo-
nies were patched onto media lacking antibiotic selection. 
The loss of the ability to grow on antibiotic-containing 
media occurred by patch ten (Fig. 5). Furthermore, after 
the organisms lost their capacity to grow on selective 
medium, we used PCR to assay for the presence of cas9, 
and found that we were unable to amplify the gene in 
patch ten (Fig. 4).
Discussion
Cas9 is toxic in Synechococcus 2973
The inability to produce a significant number of excon-
jugants with constructs containing cas9 suggests that the 
gene is toxic in Synechococcus 2973 when it is introduced 
on a medium copy number plasmid. The fact that only 
five colonies were yielded from conjugation with a con-
struct in which the cas9 RBS was removed (compared to 
the ~250 colonies with the construct lacking cas9) sug-
gests that these exconjugants are “escapees” with respect 
to cas9 toxicity. Furthermore, we conclude that the cas9 
gene cannot be stably maintained in Synechococcus at a 
medium copy number level. Although the reason behind 
Cas9 toxicity is currently unclear, one possibility is that 
S. pyogenes Cas9 has off-target effects in cyanobacte-
rial cells. The enzyme may be cleaving genomic DNA 
in regions other than those targeted by the synthetic 
sgRNA, and that the cell is unable to repair these breaks, 
thus resulting in lethality.
Transient cas9 expression achieves genome editing
After switching to a plasmid backbone that facilitated 
transient expression of cas9 (pCRISPomyces-2), we 
found that we were able to engineer the intended nblA 
deletion strain. All of the exconjugants failed to bleach 
under nitrogen deprivation conditions, suggesting that 
nblA had been edited. Since the organism cannot retain 
any functional copies of nblA to exhibit the non-bleach-
ing phenotype, this also suggests that segregation had 
occurred and only the mutated genome copy remained.
The fact that we were able to produce antibiotic-resist-
ant exconjugants shows that permissive temperature of 
replication differs between the Synechococcus 2973 sys-
tem and the Streptomyces lividans system. We believe 
that the pCRISPomyces-2 backbone replicates at a basal 
level at 38  °C in Synechococcus 2973. PCR assays show 
Fig. 2 Synechococcus 2973 exconjugants do not exhibit character-
istic bleaching under nitrogen deprivation conditions. Triparental 
mating was used to introduce the ∆nblA CRISPR/Cas9 plasmid into 
Synechococcus 2973. Exconjugants were patched onto selective 
media and then transferred to liquid cultures in standard and nitro-
gen deprivation conditions
Table 1 Conjugation results showing that the plasmid backbone has an effect on achieving successful editing
Construct Total number of  
exconjugants
Percent of exconjugants edited 
and segregated on 1st patch
pVZ321 >250 –
pVZ321 + sSpcas9 0 –
pVZ321 + nblA sgRNA, ∆nblA editing template, sSpcas9 0 N/A
pVZ321 + nblA sgRNA, ∆nblA editing template, sSpcas9 (no promoter) 0 N/A
pVZ321 + nblA sgRNA, ∆nblA editing template, sSpcas9 (no RBS) 4 0/4 (0 %)
pCRISPomyces-2 + nblA sgRNA, ∆nblA editing template, sSpcas9 21 16/16 (100 %)
pCRISPomyces-2 + nblA sgRNA, ∆nblA repair template—sSpcas9 32 3/10 (30 %)
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that cas9 was present in early patches, but not in later 
patches (Fig. 4), making it transient in nature.
The presence of cas9 improves genome editing efficiency
Although the total number of exconjugants yielded with 
a construct lacking cas9 was higher, which may be attrib-
uted to the smaller size of the construct, the rate of edit-
ing and segregation in the absence of cas9 was reduced. 
When using a construct that contains cas9, exconjugants 
are edited and segregated 100  % of the time in the first 





Fig. 3 Double homologous recombination was used to generate the 
markerless deletion. a Schematic of the double homologous recom-
bination event that results in deletion of nblA from the chromosome 
is shown. Black arrows indicate primers, yellow rectangles indicate 
homology arms, and the blue arrow represents the nblA gene. b PCR 
was used to confirm the deletion of nblA. Colony PCR using Primer A 
and Primer B of mutant Synechococcus 2973 yielded a product that is 
180 base pairs lower in molecular weight than the band produced by 
wild type culture
Fig. 4 The cas9 gene was present in early patches, but absent once 
curing had occurred. Primers were designed to sit on the pCRISPo-
myces-2 backbone, outside cas9, yielding a 4.252 kb product if the 
plasmid was present
Fig. 5 Curing of the CRISPR ∆nblA editing plasmid during consecu-
tive serial patching. Top plate exhibits the growth of nine exconju-
gants on nonselective medium, and bottom plate shows the absence 
of growth on media containing apramycin. By patch ten, no growth is 
seen on the antibiotic-containing plate
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and segregated 30 % of the time. This suggests that Cas9-
mediated cleavage accounted for roughly 70 % of editing 
in the engineered Synechococcus 2973 cells.
Edited exconjugants can be cured of the CRISPR plasmid 
machinery
Many bacterial CRISPR/Cas9 systems rely on the gen-
eration of a strain that has S. pyogenes cas9 engineered 
into the genome of the organism undergoing editing. 
However, with this system, edits are made in a genetic 
background that is distinct from the wild type organ-
ism. The benefit of introducing the CRISPR/Cas9 editing 
machinery on a plasmid is that after editing is completed, 
the foreign construct may be cured from the organism, 
leaving behind a truly “markerless” modification in a wild 
type background. Furthermore, the fact that cas9 appears 
to be toxic in cyanobacteria suggests that engineering 
cas9 into the genome is a suboptimal approach for this 
class of organisms.
The fact that the exconjugants lost the ability to grow 
on selective media after subsequent rounds of patching 
suggests that the organisms were cured of the plasmid 
containing the CRISPR/Cas9 machinery. Furthermore, 
the inability to amplify the antibiotic resistance gene after 
passaging on nonselective medium provides further con-
firmation that the organisms were cured of the plasmid. 
Thus, we were able to take advantage of one of the most 
valuable aspects of CRISPR/Cas9 genome editing: abil-
ity to generate markerless genetic modifications in a wild 
type background.
Conclusions
This is the first report of the use of a CRISPR/Cas9 
genome editing system in a cyanobacterial strain. 
Although cas9 has been used with great success to make 
genome modifications in other organisms, we found that 
in Synechococcus 2973, cas9 expression must occur in a 
transient manner to achieve successful editing. The fact 
that editing success depends on transient cas9 expres-
sion in one cyanobacterial strain suggests that cas9 tox-
icity may be the reason the application of CRISPR/Cas9 
genome editing in cyanobacteria has lagged behind that 
of other organisms. The CRISPR/Cas9 genome editing 
method described here will no doubt advance diverse sci-
entific investigation in cyanobacteria.
Methods
Bacterial strains and culture conditions
All cloning was performed in the Escherichia coli strains 
HB101 and XL1-Blue. Cells were grown at 37  °C in LB 
media in liquid or on agar plates supplemented with 
50 μg/mL apramycin or 50 μg/mL kanamycin as required. 
Synechococcus 2973 and Synechococcus 7942 cells were 
grown in BG11 medium at 38 °C under 80 μE m−2s−1 of 
continuous white light in two manners: on agar plates, 
supplemented with 20–50  μg/mL apramycin as needed 
or shaking in 125 mL Erlenmeyer flasks.
Conjugation of pCRISPomyces‑2 based nblA editing 
plasmid into Synechococcus 2973
Plasmids used for conjugation were constructed as 
described in the Additional file 1 addendum. Tri-paren-
tal mating was used to introduce the nblA-targeting 
pCRISPomyces-2 into wild type Synechococcus 2973, 
with pRL443 as the conjugal plasmid and pRL623 as the 
helper plasmid [36]. The HB101 strain, which already 
carried pRL623, was transformed with nblA-targeting 
pCRISPomyces-2 and served as the cargo-carrying 
strain in the tri-parental mating. Escherichia coli cul-
tures were inoculated approximately 17  h prior to use 
and grown to OD600  =  0.6. Cyanobacterial strains 
were also inoculated approximately 17  h prior to use 
to OD730 = 0.25, and grown to OD730 = 0.4, as meas-
ured on a μQuant Bio-Tek plate reader. All bacterial 
cultures were washed prior to use in conjugation with 
either distilled water for E. coli or BG11 for cyanobac-
teria. 100 μL of the cargo and conjugal E. coli lines were 
combined with cyanobacteria cells from 1 mL of liquid 
culture for each conjugation reaction and resuspended 
in a total volume of 300 μL. Subsequently, 100 μL of the 
conjugation reaction was plated on BG11 agar plates 
containing HATF transfer membranes (Millipore). 
In conjugation with pVZ321-based plasmids, filters 
were incubated on nonselective media for 24  h before 
transferring the membranes to BG11 agar plates sup-
plemented with 50  μg/mL kanamycin. For conjugation 
with pCRISPomyces-2- based plasmids, after 4 days, the 
membranes were moved to BG11 agar plates containing 
20 μg/mL apramycin, and after 3 more days these mem-
branes were transferred to BG11 agar plates containing 
50 μg/mL apramycin.
Assessing bleaching under nitrogen deprivation 
conditions
Exconjugants were transferred from patches to liquid cul-
tures and allowed to grow to a suitable volume and den-
sity to allow for visualization of bleaching. Cultures were 
washed three times with BG11 lacking nitrate, resus-
pended in the same media, and assessed 24 h later for dif-
ferential coloration in comparison to a wild-type sample.
PCR assays to confirm accurate editing
DreamTaq (Thermo Fisher Scientific) was used for all 
deletion confirmation reactions in addition to all of the 
reactions checking for single recombination events. The 
set composed of PrimerA/PrimerB was used to check for 
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deletion of nblA in the chromosome, the PrimerA/Prim-
erC set was used to check for single recombinants in one 
orientation, and the PrimerD/PrimerE set was used to 
check for single recombinants in the other possible ori-
entation (see Fig. 3).
Curing the CRISPR plasmid from edited strains
Exconjugants were initially selected for on BG11 agar 
plates supplemented with 20 μg/mL apramycin. The first 
patch was carried out on BG11 agar plates supplemented 
with 20 μg/mL apramycin. Subsequent patches were per-
formed on BG11 agar plates. Colonies were assayed for 
curing by the loss of ability to grow on apramycin-con-
taining media after each round of patching. After colo-
nies appeared to be cured, further testing was done via 
colony PCR, to ensure that a portion of the pCRISPo-
myces-2 backbone could not be amplified from later 
patches as opposed to amplification in earlier patches 
(Cas9ChkF/Cas9ChkR).
Abbreviations
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